blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0775126

EP0775126 - HYPOLIPIDEMIC 1,4-BENZOTHIAZEPINE-1,1-DIOXIDES [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  05.09.2003
Database last updated on 05.10.2024
Most recent event   Tooltip05.09.2003No opposition filed within time limitpublished on 22.10.2003  [2003/43]
Applicant(s)For all designated states
THE WELLCOME FOUNDATION LIMITED
Unicorn House 160 Euston Road P.O. Box 129
London NW1 2BP / GB
[N/P]
Former [1997/22]For all designated states
THE WELLCOME FOUNDATION LIMITED
Unicorn House 160 Euston Road P.O. Box 129
London NW1 2BP / GB
Inventor(s)01 / BRIEADDY, Lawrence, Edward
5924 Wintergreen Drive
Raleigh, NC 27609 / US
[1997/22]
Representative(s)Hammett, Audrey Grace Campbell
Glaxo Wellcome plc
Glaxo Wellcome House
Berkeley Avenue
Greenford
Middlesex UB6 0NN / GB
[N/P]
Former [1997/22]Hammett, Audrey Grace Campbell
Glaxo Wellcome plc, Glaxo Wellcome House, Berkeley Avenue
Greenford, Middlesex UB6 0NN / GB
Application number, filing date95927877.109.08.1995
[1997/22]
WO1995GB01884
Priority number, dateUS1994028852710.08.1994         Original published format: US 288527
[1997/22]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO9605188
Date:22.02.1996
Language:EN
[1996/09]
Type: A1 Application with search report 
No.:EP0775126
Date:28.05.1997
Language:EN
The application published by WIPO in one of the EPO official languages on 22.02.1996 takes the place of the publication of the European patent application.
[1997/22]
Type: B1 Patent specification 
No.:EP0775126
Date:30.10.2002
Language:EN
[2002/44]
Search report(s)International search report - published on:EP22.02.1996
ClassificationIPC:C07D281/10, C07D417/04, C07D513/04, A61K31/55
[1997/22]
CPC:
C07D513/04 (EP,US); A61K31/554 (EP,US); A61P3/00 (EP);
A61P3/06 (EP); A61P9/00 (EP); A61P9/10 (EP);
C07D281/10 (EP,US); C07F9/6536 (EP,US) (-)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [1997/22]
Extension statesLT04.02.1997
LV04.02.1997
SI04.02.1997
TitleGerman:LIPIDSENKENDE 1,4-BENZOTHIAZEPIN-1,1-DIOXIDE[1997/22]
English:HYPOLIPIDEMIC 1,4-BENZOTHIAZEPINE-1,1-DIOXIDES[1997/22]
French:1,4-BENZOTHIAZEPINE-1,1-DIOXYDES A ACTION HYPOLIPIDEMIQUE[1997/22]
Entry into regional phase04.02.1997National basic fee paid 
04.02.1997Designation fee(s) paid 
04.02.1997Examination fee paid 
Examination procedure30.01.1996Request for preliminary examination filed
International Preliminary Examining Authority: EP
04.02.1997Examination requested  [1997/22]
05.08.1999Despatch of a communication from the examining division (Time limit: M06)
19.01.2000Reply to a communication from the examining division
18.08.2000Despatch of a communication from the examining division (Time limit: M04)
13.12.2000Reply to a communication from the examining division
09.05.2001Despatch of communication of intention to grant (Approval: Yes)
04.01.2002Despatch of communication that the application is refused, reason: formalities examination {1}
14.03.2002Communication of intention to grant the patent
19.06.2002Fee for grant paid
19.06.2002Fee for publishing/printing paid
Divisional application(s)EP02003711.5  / EP1203769
Opposition(s)31.07.2003No opposition filed within time limit [2003/43]
Request for further processing for:19.02.2002Request for further processing filed
19.02.2002Full payment received (date of receipt of payment)
Request granted
14.03.2002Decision despatched
Fees paidRenewal fee
08.08.1997Renewal fee patent year 03
10.08.1998Renewal fee patent year 04
11.08.1999Renewal fee patent year 05
16.08.2000Renewal fee patent year 06
14.08.2001Renewal fee patent year 07
14.08.2002Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[DX]WO9316055  (WELLCOME FOUND [GB]) [DX] 1-19 * see the whole document, particularly examples 30-34 and 37-39 *;
 [PX]WO9418183  (WELLCOME FOUND [GB], et al) [PX] 1-19 * see the whole document, particularly examples 13 and 44 *;
 [PX]WO9418184  (WELLCOME FOUND [GB], et al) [PX] 1-19* see the whole document, particularly example 19 *
 [X]  - ANONYMOUS, "Pharmaceutical compounds", RESEARCH DISCLOSURE, EMSWORTH GB, vol. 354, pages 691 - 3 [X] 1-19 * the whole document *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.